IODINE I-131 APAMISTAMAB
UNII 71RR81V666

Substance Identification & Data

This profile provides standardized clinical and technical data for Iodine I-131 Apamistamab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 71RR81V666.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2097132-02-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

71RR81V666

CAS Registry Number

2097132-02-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

IODINE I-131 APAMISTAMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C2527

National Cancer Institute reference terminology for clinical and research data.

INN ID

10856

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

HI-44

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Iodine I-131 Apamistamab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

IODINE (131I) APAMISTAMAB

IODINE I 131 APAMISTAMAB

Common Names & Synonyms

APAMISTAMAB IODINE I-131

IMMUNOGLOBULIN G1, ANTI-(HUMAN CD45 ANTIGEN) (MUS MUSCULUS MONOCLONAL BC8 .GAMMA.1-CHAIN), DISULFIDE WITH MUS MUSCULUS MONOCLONAL BC8 .KAPPA.-CHAIN, DIMER, LABELED WITH IODINE-131

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS RECEPTOR-TYPE TYROSINE-PROTEIN PHOSPHATASE C (LEUKOCYTE COMMON ANTIGEN, EC=3.1.3.48, CD45 ANTIGEN)MUS MUSCULUS MONOCLONAL ANTIBODYCONJUGATED ON ~6 TYROSYL AMINOACIDS TO IODINE (131I).GAMMA.1 HEAVY CHAIN (1-445) (MUS MUSCULUS VH (IGHV4-1*02 (96%) (IGHD)-IGHJ4*01) (8.8.14) (1-121)-MUS MUSCULUS IGHG1*02 (CH1(Q78>E(199)), CH2(K57>Q(288),I63>F(294)), CH3(N31>D(369))) (122-445)) (223-218')-DISULFIDE WITH .KAPPA. LIGHT CHAIN (1'-218') (MUS MUSCULUS V-KAPPA (IGKV3-12*01 (98%) IGKJ4*01)(10.3.9) (1'-111')-MUS MUSCULUS IGKC*01 (111'-218')), DIMER (225-225'':228-228'':230-230'')-TRISDISULFIDECONJUGATED ON ~6~TYROSYL AMINOACIDS (2 PER EACH H CHAIN AND 1 PER EACH L CHAIN) TO IODINE (131I)

IODINE (131I) APAMISTAMAB [INN]

IODINE (131I) APAMISTAMAB [WHO-DD]

IODINE I 131 APAMISTAMAB [USAN]

IODINE I 131 MONOCLONAL ANTIBODY BC8

IODINE I-131 APAMISTAMAB

MOAB, BC8, MURINE, IODINE-I-131 RADIOLABELED TO CD45